Latest News

Through the new collaborating centre, WHO will expand access to structured, competency-based regulatory training and support the development of a stronger workforce capable of regulating medicines and vaccines.

The acquisition adds rare endocrine diseases as a new growth area alongside Vertex’s existing focus on cystic fibrosis, hematology, acute pain and renal disease.

The collaboration combines Weave Bio’s artificial intelligence tools with Takeda’s regulatory expertise to simplify and speed up activities involved in preparing submissions and responding to questions from health authorities.

The meeting brings together stakeholders to discuss practical approaches to strengthening Ghana’s health system and advancing national UHC priorities.

The new stockpile builds on the Access and Allocation Mechanism established in 2024 during the mpox Public Health Emergency of International Concern (PHEIC).

The agreement establishes a framework for broader cooperation between the two institutions as they respond to changing healthcare needs in Qatar.

The extended hours follow the clinic’s launch earlier this year and form part of SEHA Clinics’ efforts to improve access to preventive and community-based healthcare across Abu Dhabi.

The initiative forms part of ADCAN Pharma’s efforts to strengthen the UAE’s capacity to produce complex and specialised medicines domestically.

The guidance recommends that Ervebo® should currently be used against Bundibugyo virus (BDBV) only within a research protocol.

The platform has grown to serve about 70,000 members across more than 400 companies and connects users with more than 1,200 pharmacies and healthcare providers in the two countries.